The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Virios Therapeutics, LLC(NASDAQ:VIRI)


Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fi...
Share this website to your friends
Virios Therapeutics LLC Op Cashflow Per Share ttm
Virios Therapeutics LLC Free Cashflow Per Share ttm
Virios Therapeutics LLC Cash Per Share ttm
Virios Therapeutics LLC (GAAP) P/E ratio ttm
Virios Therapeutics LLC P/B ratio ttm
No extra charts and metrics for this ticker.